| Variable | Overall | Male | Female | FRS groups | ||
| <10% | 10–20% | >20%, or CVD or DM | ||||
| Subjects n | 5485 | 2503 | 2982 | 4361 | 555 | 569 |
| Age yrs | 43.0±16.8 | 43.4±16.9 | 42.7±16.7 | 37.6 | 66.0 | 62.1 |
| Total cholesterol mg·dL−1 | 203.6±43.4 | 203.7±42.1 | 203.5±44.4 | 198.0 | 225.8 | 225.3 |
| HDL-C mg·dL−1 | 51.8±14.9 | 47.1±12.9** | 55.7±15.3 | 53.1 | 47.7 | 45.5 |
| Systolic BP mmHg | 122.4±18.0 | 125.7±16.0** | 119.7±19.1 | 117.9 | 138.8 | 141.3 |
| FVC % pred | 104.0±19.1 | 103.9±18.7 | 104.2±19.4 | 104.4 | 104.7 | 100.6 |
| FEV1 % pred | 102.5±19.0 | 102.0±18.9 | 103.0±19.1 | 103.1 | 101.4 | 98.8 |
| Anti-HTN medication % | 9.5 | 9.0 | 9.9 | 5.2** | 27.7** | 39.7** |
Data are presented as mean±sd, unless otherwise stated. CVD: cardiovascular disease; DM: diabetes mellitus; HDL-C: high-density lipoprotein cholesterol; BP: blood pressure; FVC: forced vital capacity; % pred: % predicted; FEV1: forced expiratory volume in 1 s; HTN: hypertension. **: p<0.01 indicates significant difference when compared across sex or ethnicity.